Update on Long-Acting Anticholinergics in Children and Adolescents With Difficult and Severe Asthma

Tiotropium bromide is the only long-acting muscarinic antagonist (LAMA) approved for treatment of patients aged ≥6 years old who have symptoms of uncontrolled asthma. Results from several clinical trials have found that once-daily inhaled tiotropium bromide is safe and efficacious in 6- to 17-year-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Santamaria, Francesca, Ziello, Carla, Lorello, Paola, Bouchè, Cristina, Borrelli, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343620/
https://www.ncbi.nlm.nih.gov/pubmed/35928684
http://dx.doi.org/10.3389/fped.2022.896865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343620/
https://www.ncbi.nlm.nih.gov/pubmed/35928684
http://dx.doi.org/10.3389/fped.2022.896865

Ejemplares similares